Xofluza
NDC 85766-058, BALOXAVIR MARBOXIL, tablet, film coated, from Sportpharm LLC.
- Product NDC
- 85766-058
- Status
- Listed
- Labeler
- Sportpharm LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210854
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85766-058 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BALOXAVIR MARBOXIL80 mg/1
Pharmacologic classes
Chelating Activity [MoA]; Polymerase Acidic Endonuclease Inhibitor [EPC]; Polymerase Acidic Endonuclease Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85766-058-01 | 85766005801 | 1 BLISTER PACK in 1 CARTON (85766-058-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b58b2899-4d22-41e1-8f0c-bdead8917694
Use it
Look up 85766-058 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85766-058 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85766-058. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.